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SHORT COMMUNICATION
Hidradenitis suppurativa (HS) is a chronic, debilitating, 
inflammatory skin condition that affects 1% of the 
general population (1). The disease predominantly af-
fects inverse areas of the body like the axillae and the 
groins, and presents with painful, inflammatory nodules, 
abscesses, sinus tracts, pseudocomedones and scarring 
(1). HS is difficult to treat. In severe HS, sinus tracts, 
fibrotic tissue and architectural loss will remain after 
pharmacological therapy. Surgery is the only approach 
able to remove these lesions (1, 2). In Hurley stage I/II the 
de-roofing technique is widely used (3). Wide excision 
is often performed in Hurley stage II/III as it reaches 
deeper structures (4). We have previously described a 
new surgical technique for Hurley stage II/III: the Skin-
Tissue-sparing Excision with Electrosurgical Peeling 
(STEEP) procedure. Briefly, during STEEP all affected 
tissue is removed by subsequent tangential transections, 
whilst saving as much healthy tissue as possible. In 
theory, this leads to rapid healing, satisfying cosmetic 
results and prevention of contractures (5, 6). 
This prospective study aimed to investigate the short- 
and mid-term outcomes of the STEEP procedure. 
MATERIALS AND METHODS
All patients who underwent the STEEP procedure for HS Hurley 
II/III in our tertiary centre in February and March 2014 were 
included. The University Medical Center Groningen (UMCG) 
ethics committee granted exemption for reviewing our study 
protocol. The STEEP procedure was performed as part of stan-
dard medical treatment (6). The surgery was conducted under 
general anaesthesia and performed by 2 surgeons (JBT and JRS). 
Short-term follow-up took place every 2 weeks until complete 
wound closure was achieved. Long-term follow-up was perfor-
med after at least 6 months. Primary outcomes were: (i) time to 
complete wound closure (TCWC), measured in days; (ii) wound 
healing, defined as progression of wound closure in cm2 at the 
different time-points; (iii) influencing factors on wound healing; 
(iv) patients’ satisfaction; and (v) recurrences. Wound closure 
was defined as complete epithelialization of the wound. Various 
variables were tested to determine whether they were predictive 
for the logarithmic TCWC, such as logarithmic size of the wound, 
operation location, age, body mass index (BMI), sex, smoking, 
Sartorius score and Hurley stage. Patient satisfaction was mea-
sured 8 weeks postoperatively with a questionnaire containing 3 
questions: (i) satisfaction about the functional result on a scale 
of 1 to 10, where 1 corresponds to very dissatisfied and 10 to 
excellent; (ii) satisfaction about the cosmetic result on a scale of 
1 to 10; and (iii) recommendation of the treatment to other pe-
ople. Recurrences of HS activity after surgery were divided into 
2 categories, as described previously: (i) relapse and (ii) natural 
progression (5). Relapse due to inadequate radical surgery was 
defined as inflammatory activity occurring within 0.5 cm of the 
surgical scar, and natural progression was defined as inflammation 
that developed outside this area in the same anatomical region (3, 
5). Secondary outcomes were: (i) absence from work, measured 
in days; and (ii) complications (hypergranulation, nerve damage, 
infections, secondary bleeding and contractures). The imaging 
program Adobe Photoshop (version CS4, Adobe Systems) was 
used to measure the surface of the wounds in photographs. The 
photographs were taken under standardized conditions, using a 
calibration scale for each photograph. Relationships between 
possible risk factors and the TCWC are analysed with a mixed 
model (random intercept model) to accommodate the healing 
time for multiple wounds on the same patient. The logarithmic 
transformed TCWC was analysed. A p-value < 0.05 is seen as 
significant. Statistical analysis was performed with IBM SPSS 
statistics version 20.0 or with SAS, SAS Institute, version 9.3.
RESULTS
A total of 16 patients with 27 operation sites were in-
cluded. The median size of the wounds was 14.93 cm2. 
Patient characteristics are shown in Table SI1; Fig. S11 
shows the clinical course of wound healing in 3 patients. 
Long-term follow-up was completed in all patients 
after a mean of 8.26 months (SD 0.90). Eight patients 
were using anti-inflammatory agents (all second-line 
treatments) during the study period. Five patients were 
using infliximab, 5 mg/kg/day, once every 6–8 weeks. 
The mean duration of use of infliximab before STEEP 
was 29.8 months (range 11–57 months), all patients 
continued infliximab after STEEP. The mean TCWC 
was 53.1 days (SD 24.0). In 2 weeks there was a mean 
wound closure of 49.0%. Progressive wound healing was 
most marked in the first 4 weeks. The size of the wound 
and the Hurley stage were independent predictors of 
the TCWC (p < 0.001 and p = 0.009, respectively). The 
median score for patient satisfaction was 8.7 (3.5–10.0) 
for the func tional outcome and 7.2 (2.5–10.0) for the 
cosmetic outcome. Furthermore, all 16 patients would 
recommend the procedure to other patients. In total, 8 of 
the 16 patients had a recurrence. In one of these patients 
the recurrence occurred after 274 days, while in 7 patients 
there was natural progression. The relapse occurred in 
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a patient without anti-inflammatory medication. Four 
of the 8 patients without anti-inflammatory therapy had 
natural progression, while 3 of the 8 patients with anti-
inflammatory therapy developed natural progression. 
After a mean of 28.1 days (SD 15.5) patients had returned 
to work full-time. The most common complication was 
hypergranulation (62.4% of patients) in which treatment 
with clobetasol 0.05% cream was applied with adequate 
response. No other complications were experienced. 
DISCUSSION
The use of STEEP in HS has several advantages over 
other surgical procedures. Healing times are shorter and 
the risk of complications is lower compared with wide 
excision, probably due to tissue sparing. In both STEEP 
and carbon dioxide (CO2) laser vaporization there is good 
visibility of the pathological tissues in the surgical field 
due to proper haemostasis. However, in STEEP the depth 
of the excision can be adjusted easily within a single 
transection, while the tissue that is removed by CO2 
laser has a single continuous fixed layer of thickness (6). 
In our view, STEEP is indicated in HS Hurley II–III of 
the body folds, as these areas are prone to the formation 
of contractures after surgery (5). Because STEEP aims 
to save as much healthy tissue as possible, the formation 
of contractures is avoided and shorter healing times can 
be achieved (5, 6). However, different techniques can be 
combined in the same patient, in order to benefit from 
their individual advantages.
This case series is the first prospective study in STEEP. 
The TCWC is satisfactory, at 7.6 weeks. Three previous 
studies, investigating wide excision with secondary hea-
ling in Hurley II/III patients, showed a TCWC ranging 
between 11.3 and 12.2 weeks (7–9). Unfortunately, the 
mean size of the wounds was not mentioned in these stu-
dies. As healing times correspond to the size of the wounds 
and Hurley grade, the clinician can use this information 
to optimize the planning of surgery and follow-up. Our 
patient satisfaction is similar to the results of van der 
Zee et al. (3), who treated Hurley I/II HS patients with 
de-roofing. Because of the lack of uniform definitions of 
recurrences in the current literature, it is difficult to make 
firm statements about the efficacy of STEEP. Mikkelsen et 
al. (10) investigated the efficacy of CO2 laser in HS; 29% 
of the patients had HS activity within the borders of the 
treated areas. In our study, only one patient (6.3%) showed 
a relapse. Ritz et al. (11) defined recurrences as persistent 
or newly developed signs of HS appearing in the same 
anatomical area. Recurrence was seen in 42.8% of patients 
after limited regional excision and 27.0% after radical wide 
excision. Our 50.0% recurrence rate is quite similar to the 
recurrence rate after limited regional excision. Thus, the 
advantage of the lower recurrence rates after radical wide 
excision should be weighed against the burden of larger 
surgical wounds. After treatment with a CO2 laser, absence 
from work ranged between 3 days and 3 weeks (12). 
Compared with our data (4 weeks), this is a short period 
of time. The shorter absence from work can be explained 
by Hurley grade II and smaller wound sizes (5–50 cm2) in 
the CO2 laser study. The STEEP procedure appears safe, 
as none of our patients developed severe complications. 
The frequency of complications after wide excision are 
higher, with 10.9% infections, 7% postoperative bleeding 
and 7% contractures (13). The limitations of this study are 
the relatively small study size, a possible inter-operator 
variation, and the heterogeneity of the study population.
In conclusion, the STEEP procedure should be con-
sidered as surgical treatment for HS Hurley stage II/
III patients. 
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